X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/compugen-publishes-paper-in-cancer-immunology-research-demonstrating-therapeutic-potential-of-com503-302112780.html
https://www.prnewswire.com/news-releases/compugen-to-participate-in-two-upcoming-investor-conferences-302107006.html
https://www.prnewswire.com/news-releases/compugen-selected-for-two-oral-presentations-at-the-keystone-symposium-on-cancer-immunotherapy-302085114.html
https://www.prnewswire.com/news-releases/compugen-to-present-data-reflecting-its-diversified-immuno-oncology-pipeline-at-aacr-2024-302081057.html
https://www.prnewswire.com/news-releases/compugen-reports-fourth-quarter-and-full-year-2023-results-302079674.html
https://www.prnewswire.com/news-releases/compugen-to-present-at-the-leerink-partners-global-biopharma-conference-2024-302070842.html
https://www.prnewswire.com/news-releases/compugen-to-release-fourth-quarter-and-full-year-2023-results-on-tuesday-march-5-2024-302065833.html
https://www.prnewswire.com/news-releases/compugen-announces-appointment-of-michelle-mahler-md-as-chief-medical-officer-302062841.html
https://www.prnewswire.com/news-releases/compugen-to-receive-10-million-milestone-payment-following-dosing-of-first-patient-in-astrazeneca-phase-3-rilvegostomig-trial-in-biliary-tract-cancer-302028318.html
https://www.prnewswire.com/news-releases/compugen-regains-compliance-with-nasdaq-minimum-bid-price-requirement-302028313.html
Market Place
Share 
